IBO Releases 2012 Instrument Industry Forecast
News Apr 13, 2012
The analytical and life science instrument industry is forecast to grow 5.5% this year to approximately $44.7 billion, according to Strategic Directions International (SDi), a market research and consulting firm that tracks the instrument industry.
The forecast appears in the January 15, 2012, issue of Instrument Business Outlook (IBO).
The market for analytical and life science instruments, which includes aftermarket products and service, increased an estimated 7.1% in 2011, according to SDi.
The special IBO issue features detailed 2012 forecasts, including sales growth and market share information for ten instrument categories: separations techniques, such as HPLC and gas chromatography; life science instruments, including sequencers and microarrays; mass spectrometry; laboratory automation systems; atomic spectroscopy; molecular spectroscopy; surface science techniques, such as microscopy; materials characterization techniques; general analytical techniques; and laboratory equipment.
The issue also includes forecasts for instrument sales by end-user market and region.
Driving instrument sales growth in 2012 will be demand for mass spectrometry and surface science.
Growth in demand from the biotech, food and pharmaceutical industries, as well as independent test labs, particularly CROs, and government and academia, is also expected to stimulate sales.
Thermo, SRI International Collaborate to Enhance Small Molecule ResearchNews
Thermo set to collaborate with SRI International to combine results of Orbitrap LC/MS experiments with organism-specific metabolic pathway and genome data to improve small molecule research and analysis.READ MORE
One-step Protein Purification Achieves High Yields, Purity and ActivityNews
A novel method to improve the high-yield, high-purity, high-activity purification of complex proteins by 10- to 500-fold has been developed at the University of Alabama at BirminghamREAD MORE
Advanced Cancer Drug Study Highlights Need for Novel ApproachesNews
The pre-clinical findings, just published in Cell Chemical Biology, may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer.READ MORE
Comments | 0 ADD COMMENT
18th International Conference and Exhibition on Analytical & Bioanalytical Chromatographic Techniques
Nov 02 - Nov 03, 2017
8th Edition of International Conference on Mass Spectromerty
Mar 12 - Mar 13, 2018